PTN Competitors & Alternatives

Compare Palatin Technologies, Inc. Common Stock with similar stocks in the same industry

Biotechnology

PTN

Main Stock
$6.13
-1.69%
Tradestie Score
31
Revenue Growth
-80.1%
Analyst Upside
+604.1%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: Melanocortin receptor agonists, Peptide therapeutics development
Major Customers 5
Specialty pharmacies Healthcare providers Patients with HSDD License partners Clinical research organizations
Critical Suppliers 5
Contract manufacturing organizations API suppliers Clinical trial sites Distribution partners Regulatory consultants
Direct Ecosystem Rivals 4

Top Competitors

221 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$7.12
-1.79%
$137.59M - 42 Compare
CLYM Climb Bio, Inc. Common Stock
$9.94
-4.05%
$133.50M - 45 Compare
ATOS Atossa Therapeutics, Inc. Common Stock
$1.93
-1.53%
$118.35M - 58 Compare
SRZN Surrozen, Inc. Common
$32.32
+2.25%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$27.12
-8.19%
$110.20M - 32 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.02
-2.89%
$84.52M - 53 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.48
-4.59%
$67.94M - 52 Compare
MBIO Mustang Bio, Inc.
$0.39
-6.34%
$11.37M - 40 Compare
OGEN Oragenics Inc.
$0.20
-1.49%
$5.86M - 35 Compare
JAGX Jaguar Health, Inc.
$0.39
-7.74%
$4.85M - 54 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC None)

221 stocks in this industry